Kidney and Bladder Cancers :@0.646100:0.035749:0.919881:0.035749:0.919881:0.019993:0.646100:0.019993:0.011372:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330:0.013143:0.011738:0.013181:0.005330:0.011045:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
67:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Dr PW van Zijl:@0.084848:0.160749:0.207615:0.160749:0.207615:0.144715:0.084848:0.144715:0.013470:0.006158:0.005388:0.010776:0.017318:0.005388:0.010776:0.012700:0.011545:0.005388:0.009621:0.004618:0.005003:0.004618
MBChB, MMed, FC Rad Onc:@0.084848:0.177087:0.343851:0.177087:0.343851:0.160868:0.084848:0.160868:0.017318:0.011161:0.015009:0.011545:0.011161:0.005388:0.005388:0.017318:0.017318:0.012315:0.012700:0.005388:0.005388:0.009236:0.015009:0.005388:0.011161:0.012700:0.012700:0.005388:0.016164:0.011545:0.012315
 :@0.084848:0.193306:0.121236:0.193306:0.121236:0.178622:0.084848:0.178622:0.017145:0.019242
Clinical and Radiation Oncologist :@0.121236:0.193425:0.439447:0.193425:0.439447:0.177669:0.121236:0.177669:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.013143:0.011738:0.013181:0.005330:0.011680:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.016722:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.005330
in private practice, Life Wilgers Hospital, :@0.084848:0.209763:0.458482:0.209763:0.458482:0.194007:0.084848:0.194007:0.003848:0.011738:0.005330:0.013123:0.005792:0.003848:0.010660:0.013143:0.006523:0.012508:0.005330:0.013123:0.005792:0.013143:0.012450:0.006523:0.003848:0.012450:0.012508:0.005330:0.005330:0.008890:0.003848:0.006042:0.012508:0.005330:0.018573:0.003848:0.003848:0.012950:0.012508:0.005792:0.007466:0.005330:0.013143:0.012604:0.007466:0.013123:0.003848:0.006523:0.013143:0.003848:0.005330:0.005330
Pretoria:@0.084848:0.226101:0.156367:0.226101:0.156367:0.210345:0.084848:0.210345:0.011392:0.005709:0.012508:0.006523:0.012604:0.005792:0.003848:0.013143
KIDNEY CANCER:@0.084848:0.259457:0.270644:0.259457:0.270644:0.239860:0.084848:0.239860:0.014581:0.006585:0.016463:0.017404:0.012230:0.014581:0.006585:0.018344:0.017404:0.017404:0.018344:0.012230:0.013641
The two most common types of kidney :@0.084848:0.278093:0.481088:0.278093:0.481088:0.262337:0.084848:0.262337:0.008197:0.011738:0.012508:0.010564:0.006523:0.015990:0.012604:0.010564:0.018049:0.012604:0.007466:0.006523:0.010564:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.010564:0.006523:0.010314:0.013123:0.012508:0.007466:0.010564:0.012604:0.006042:0.010564:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330
cancer  are  renal cell carcinoma  (RCC) :@0.084848:0.294431:0.481099:0.294431:0.481099:0.278675:0.084848:0.278675:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.004984:0.013143:0.005715:0.012508:0.005330:0.004990:0.005713:0.012508:0.011738:0.013143:0.003848:0.010333:0.012450:0.012508:0.003848:0.003848:0.010333:0.012450:0.013143:0.005659:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.004990:0.007100:0.011680:0.015644:0.015644:0.007100:0.005330
and urothelial carcinoma of the renal pel-:@0.084848:0.310769:0.475779:0.310769:0.475779:0.295013:0.084848:0.295013:0.013143:0.011738:0.013181:0.005349:0.011699:0.005711:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.013143:0.003848:0.005349:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005349:0.012604:0.006042:0.005340:0.006523:0.011738:0.012508:0.005349:0.005711:0.012508:0.011738:0.013143:0.003848:0.005349:0.013123:0.012508:0.003848:0.006388
vis. RCC constitutes approximately 85% of :@0.084848:0.327107:0.481107:0.327107:0.481107:0.311352:0.084848:0.311352:0.010660:0.003848:0.007466:0.005330:0.006254:0.011680:0.015644:0.015644:0.006244:0.012450:0.012604:0.011738:0.007466:0.006523:0.003848:0.006523:0.011699:0.006523:0.012508:0.007466:0.006240:0.013143:0.013123:0.013123:0.005719:0.012604:0.009236:0.003848:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.006254:0.010660:0.010660:0.014913:0.006254:0.012604:0.006042:0.005330
primary renal neoplasms. Urothelial (transi-:@0.084848:0.343445:0.475748:0.343445:0.475748:0.327690:0.084848:0.327690:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.005061:0.005711:0.012508:0.011738:0.013143:0.003848:0.005061:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.007466:0.005330:0.005061:0.012604:0.005709:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.013143:0.003848:0.005061:0.007100:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.006388
tional cell) carcinomas of the renal pelvis :@0.084848:0.359783:0.481096:0.359783:0.481096:0.344028:0.084848:0.344028:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006850:0.012450:0.012508:0.003848:0.003848:0.007100:0.006850:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007466:0.006850:0.012604:0.006042:0.006841:0.006523:0.011738:0.012508:0.006850:0.005713:0.012508:0.011738:0.013143:0.003848:0.006850:0.013123:0.012508:0.003848:0.010660:0.003848:0.007466:0.005330
account for approximately 8% of kidney :@0.084848:0.376122:0.481088:0.376122:0.481088:0.360366:0.084848:0.360366:0.013143:0.012450:0.012450:0.012604:0.011699:0.011738:0.006523:0.009044:0.006042:0.012604:0.005792:0.009044:0.013143:0.013123:0.013123:0.005715:0.012604:0.009236:0.003848:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.009044:0.010660:0.014913:0.009044:0.012604:0.006042:0.009044:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330
tumours, and other parenchymal epithe-:@0.084848:0.392460:0.475777:0.392460:0.475777:0.376704:0.084848:0.376704:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.008022:0.013143:0.011738:0.013181:0.008043:0.012604:0.006523:0.011738:0.012508:0.005792:0.008024:0.013123:0.013143:0.005717:0.012508:0.011738:0.012450:0.011738:0.010314:0.018049:0.013143:0.003848:0.008043:0.012508:0.013123:0.003848:0.006523:0.011738:0.012508:0.006388
lial tumours are rare. The rest of this discus-:@0.084848:0.408798:0.475758:0.408798:0.475758:0.393042:0.084848:0.393042:0.003848:0.003848:0.013143:0.003848:0.005407:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005394:0.013143:0.005715:0.012508:0.005397:0.005792:0.013143:0.005709:0.012508:0.005330:0.005394:0.008197:0.011738:0.012508:0.005388:0.005713:0.012508:0.007466:0.006523:0.005396:0.012604:0.006042:0.005397:0.006523:0.011738:0.003848:0.007466:0.005397:0.013181:0.003848:0.007466:0.012450:0.011699:0.007464:0.006388
sion will focus on RCC, while urothelial cell :@0.084848:0.425136:0.481094:0.425136:0.481094:0.409380:0.084848:0.409380:0.007466:0.003848:0.012604:0.011738:0.005542:0.015990:0.003848:0.003848:0.003848:0.005542:0.006042:0.012604:0.012450:0.011699:0.007466:0.005532:0.012604:0.011738:0.005532:0.011680:0.015644:0.015644:0.005330:0.005530:0.015990:0.011738:0.003848:0.003848:0.012508:0.005542:0.011699:0.005713:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.013143:0.003848:0.005542:0.012450:0.012508:0.003848:0.003848:0.005330
carcinomas are covered in the section on :@0.084848:0.441474:0.481101:0.441474:0.481101:0.425718:0.084848:0.425718:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007466:0.005263:0.013143:0.005715:0.012508:0.005257:0.012450:0.012604:0.010660:0.012508:0.005711:0.012508:0.013181:0.005259:0.003848:0.011738:0.005261:0.006523:0.011738:0.012508:0.005259:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005257:0.012604:0.011738:0.005330
bladder cancer.:@0.084848:0.457812:0.236948:0.457812:0.236948:0.442056:0.084848:0.442056:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330
EPIDEMIOLOGY:@0.084848:0.490882:0.241781:0.490882:0.241781:0.473067:0.084848:0.473067:0.011118:0.011973:0.005987:0.014966:0.011118:0.019242:0.005987:0.017960:0.009407:0.017960:0.017960:0.013256
The incidence of RCC varies globally from :@0.084848:0.508373:0.481086:0.508373:0.481086:0.492617:0.084848:0.492617:0.008197:0.011738:0.012508:0.005505:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005509:0.012604:0.006042:0.005509:0.011680:0.015644:0.015644:0.005511:0.010660:0.013143:0.005792:0.003848:0.012508:0.007466:0.005523:0.012950:0.003848:0.012604:0.013123:0.013143:0.003848:0.003848:0.010314:0.005523:0.006042:0.005711:0.012604:0.018049:0.005330
region  to  region,  with  the  United  States :@0.084848:0.524711:0.481098:0.524711:0.481098:0.508955:0.084848:0.508955:0.005713:0.012508:0.012950:0.003848:0.012604:0.011738:0.005330:0.005120:0.006523:0.012604:0.005330:0.005122:0.005713:0.012508:0.012950:0.003848:0.012604:0.011738:0.005330:0.005330:0.005124:0.015990:0.003848:0.006523:0.011738:0.005330:0.005128:0.006523:0.011738:0.012508:0.005330:0.005122:0.012604:0.011738:0.003848:0.006523:0.012508:0.013181:0.005330:0.005126:0.009583:0.006523:0.013143:0.006523:0.012508:0.007466:0.005330
having approximately  65  000  new cases :@0.084848:0.541049:0.481086:0.541049:0.481086:0.525293:0.084848:0.525293:0.011738:0.013143:0.010660:0.003848:0.011738:0.012950:0.009005:0.013143:0.013123:0.013123:0.005719:0.012604:0.009236:0.003848:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.005330:0.003687:0.010660:0.010660:0.005330:0.003698:0.010660:0.010660:0.010660:0.005330:0.003693:0.011738:0.012508:0.015990:0.009005:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330
annually and approximately 13 500 deaths :@0.084848:0.557387:0.481065:0.557387:0.481065:0.541631:0.084848:0.541631:0.013143:0.011738:0.011738:0.011699:0.013143:0.003848:0.003848:0.010314:0.004060:0.013143:0.011738:0.013181:0.004060:0.013143:0.013123:0.013123:0.005717:0.012604:0.009236:0.003848:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.004060:0.010660:0.010660:0.004060:0.010660:0.010660:0.010660:0.004074:0.013181:0.012508:0.013143:0.006523:0.011738:0.007466:0.005330
each year. In South  Africa,  there are an :@0.084848:0.573725:0.481123:0.573725:0.481123:0.557969:0.084848:0.557969:0.012508:0.013143:0.012450:0.011738:0.008736:0.010314:0.012508:0.013143:0.004380:0.005330:0.008736:0.004349:0.011738:0.008736:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.003391:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.005330:0.003394:0.006523:0.011738:0.012508:0.005707:0.012508:0.008736:0.013143:0.005715:0.012508:0.008736:0.013143:0.011738:0.005330
estimated 500 to 600 new cases per year. :@0.084848:0.590063:0.481098:0.590063:0.481098:0.574307:0.084848:0.574307:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.013181:0.006242:0.010660:0.010660:0.010660:0.006254:0.006523:0.012604:0.006235:0.010660:0.010660:0.010660:0.006254:0.011738:0.012508:0.015990:0.006238:0.012450:0.013143:0.007466:0.012508:0.007466:0.006254:0.013123:0.012508:0.005792:0.006238:0.010314:0.012508:0.013143:0.004381:0.005330:0.005330
RCC is approximately 50% more common :@0.084848:0.606401:0.481105:0.606401:0.481105:0.590645:0.084848:0.590645:0.011680:0.015644:0.015644:0.006167:0.003848:0.007466:0.006177:0.013143:0.013123:0.013123:0.005717:0.012604:0.009236:0.003848:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.006177:0.010660:0.010660:0.014913:0.006177:0.018049:0.012604:0.005711:0.012508:0.006167:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330
in men compared to women, occurring :@0.084848:0.622739:0.481124:0.622739:0.481124:0.606983:0.084848:0.606983:0.003848:0.011738:0.009525:0.018049:0.012508:0.011738:0.009525:0.012450:0.012604:0.018049:0.013123:0.013143:0.005713:0.012508:0.013181:0.009525:0.006523:0.012604:0.009525:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.009525:0.012604:0.012450:0.012450:0.011699:0.005792:0.005792:0.003848:0.011738:0.012950:0.005330
predominantly in the sixth to eighth dec-:@0.084848:0.639077:0.475758:0.639077:0.475758:0.623321:0.084848:0.623321:0.013123:0.005715:0.012508:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.011738:0.006523:0.003848:0.010314:0.007745:0.003848:0.011738:0.007745:0.006523:0.011738:0.012508:0.007739:0.007466:0.003848:0.009236:0.006523:0.011738:0.007745:0.006523:0.012604:0.007739:0.012508:0.003848:0.012950:0.011738:0.006523:0.011738:0.007737:0.013181:0.012508:0.012450:0.006388
ade, with the median age of diagnosis at :@0.084848:0.655415:0.481105:0.655415:0.481105:0.639659:0.084848:0.639659:0.013143:0.013181:0.012508:0.005330:0.006042:0.015990:0.003848:0.006523:0.011738:0.006042:0.006523:0.011738:0.012508:0.006031:0.018049:0.012508:0.013181:0.003848:0.013143:0.011738:0.006042:0.013143:0.012950:0.012508:0.006042:0.012604:0.006042:0.006032:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.006042:0.013143:0.006523:0.005330
64 years.:@0.084848:0.671753:0.166051:0.671753:0.166051:0.655997:0.084848:0.655997:0.010660:0.010660:0.005330:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
RISK FACTORS:@0.084848:0.705141:0.241011:0.705141:0.241011:0.685545:0.084848:0.685545:0.013641:0.006585:0.012230:0.014581:0.006585:0.011289:0.017404:0.018344:0.009878:0.019756:0.013641:0.012230
Cigarette-smoking possibly contributes to :@0.084848:0.723778:0.481098:0.723778:0.481098:0.708022:0.084848:0.708022:0.015644:0.003848:0.012950:0.013143:0.005715:0.012508:0.006523:0.006523:0.012508:0.006388:0.007466:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.007874:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.010314:0.007905:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.012508:0.007466:0.007880:0.006523:0.012604:0.005330
one-third of cases and is also associated :@0.084848:0.740116:0.481092:0.740116:0.481092:0.724360:0.084848:0.724360:0.012604:0.011738:0.012508:0.006388:0.006523:0.011738:0.003848:0.005665:0.013181:0.007716:0.012604:0.006042:0.007703:0.012450:0.013143:0.007466:0.012508:0.007466:0.007716:0.013143:0.011738:0.013181:0.007716:0.003848:0.007466:0.007716:0.013143:0.003848:0.007466:0.012604:0.007707:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330
with more advanced disease at presenta-:@0.084848:0.756454:0.475750:0.756454:0.475750:0.740698:0.084848:0.740698:0.015990:0.003848:0.006523:0.011738:0.005003:0.018049:0.012604:0.005713:0.012508:0.005003:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005003:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005016:0.013143:0.006523:0.005003:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006388
tion.  Hypertension and obesity, occupa-:@0.084848:0.772792:0.475767:0.772792:0.475767:0.757036:0.084848:0.757036:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.004147:0.013143:0.010314:0.013123:0.012508:0.005792:0.006523:0.012508:0.011738:0.007466:0.003848:0.012604:0.011738:0.009487:0.013143:0.011738:0.013181:0.009487:0.012604:0.013123:0.012508:0.007466:0.003848:0.006523:0.010314:0.005330:0.009487:0.012604:0.012450:0.012450:0.011699:0.013123:0.013143:0.006388
tional exposure to toxic compounds such :@0.084848:0.789130:0.481101:0.789130:0.481101:0.773374:0.084848:0.773374:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006870:0.012508:0.009236:0.013123:0.012604:0.007466:0.011699:0.005709:0.012508:0.006870:0.006523:0.012604:0.006856:0.006523:0.012604:0.009236:0.003848:0.012450:0.006858:0.012450:0.012604:0.018049:0.013123:0.012604:0.011699:0.011738:0.013181:0.007466:0.006856:0.007466:0.011699:0.012450:0.011738:0.005330
as cadmium,  asbestos and  petroleum :@0.084848:0.805468:0.481099:0.805468:0.481099:0.789712:0.084848:0.789712:0.013143:0.007466:0.014913:0.012450:0.013143:0.013181:0.018049:0.003848:0.011699:0.018049:0.005330:0.005330:0.009571:0.013143:0.007466:0.013123:0.012508:0.007466:0.006523:0.012604:0.007466:0.014913:0.013143:0.011738:0.013181:0.005330:0.009571:0.013123:0.012508:0.006523:0.005711:0.012604:0.003848:0.012508:0.011699:0.018049:0.005330
products, analgesic abuse and nephrop-:@0.084848:0.821806:0.475750:0.821806:0.475750:0.806050:0.084848:0.806050:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.006523:0.007466:0.005330:0.007197:0.013143:0.011738:0.013143:0.003848:0.012950:0.012508:0.007466:0.003848:0.012450:0.007197:0.013143:0.013123:0.011699:0.007466:0.012508:0.007197:0.013143:0.011738:0.013181:0.007197:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.013123:0.006388
athy all contribute to the development of :@0.084848:0.838144:0.481107:0.838144:0.481107:0.822388:0.084848:0.822388:0.013143:0.006523:0.011738:0.010314:0.005965:0.013143:0.003848:0.003848:0.005965:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.012508:0.005965:0.006523:0.012604:0.005965:0.006523:0.011738:0.012508:0.005956:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.018049:0.012508:0.011738:0.006523:0.005956:0.012604:0.006042:0.005330
RCC.  Acquired cystic disease of  the  kid-:@0.084848:0.854482:0.475771:0.854482:0.475771:0.838726:0.084848:0.838726:0.011680:0.015644:0.015644:0.005330:0.005330:0.003029:0.014239:0.012450:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.008370:0.012450:0.010314:0.007466:0.006523:0.003848:0.012450:0.008370:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012519:0.008370:0.012604:0.006042:0.005330:0.003029:0.006523:0.011738:0.012508:0.005330:0.003027:0.009660:0.003848:0.013181:0.006388
ney, chronic hepatitis C infection and sick-:@0.084848:0.870820:0.475746:0.870820:0.475746:0.855064:0.084848:0.855064:0.011738:0.012508:0.010314:0.005330:0.004487:0.012450:0.011738:0.005713:0.012604:0.011738:0.003848:0.012450:0.004487:0.011738:0.012508:0.013123:0.013143:0.006523:0.003848:0.006523:0.003848:0.007466:0.004503:0.015644:0.004491:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.004470:0.013143:0.011738:0.013181:0.004491:0.007466:0.003848:0.012450:0.009660:0.006388
le cell disease are also linked to increased :@0.084848:0.887158:0.481092:0.887158:0.481092:0.871402:0.084848:0.871402:0.003848:0.012508:0.005272:0.012450:0.012508:0.003848:0.003848:0.005272:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005272:0.013143:0.005713:0.012508:0.005272:0.013143:0.003848:0.007466:0.012604:0.005272:0.003848:0.003848:0.011738:0.009660:0.012508:0.013181:0.005272:0.006523:0.012604:0.005259:0.003848:0.011738:0.012450:0.005715:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330
incidence of RCC.:@0.084848:0.903496:0.256721:0.903496:0.256721:0.887740:0.084848:0.887740:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005330:0.012604:0.006042:0.005330:0.011680:0.015644:0.015644:0.005330
Although most RCCs are sporadic, sev-:@0.103032:0.919834:0.475767:0.919834:0.475767:0.904078:0.103032:0.904078:0.014239:0.003848:0.006523:0.011738:0.012604:0.011699:0.012950:0.011738:0.007381:0.018049:0.012604:0.007466:0.006523:0.007399:0.011680:0.015644:0.015644:0.007466:0.007408:0.013143:0.005715:0.012508:0.007397:0.007466:0.013123:0.012604:0.005792:0.013143:0.013181:0.003848:0.012450:0.005330:0.007408:0.007466:0.012508:0.010660:0.006388
eral syndromes associated with RCC have :@0.084848:0.936172:0.481078:0.936172:0.481078:0.920416:0.084848:0.920416:0.012508:0.005792:0.013143:0.003848:0.005022:0.007466:0.010314:0.011738:0.013181:0.005713:0.012604:0.018049:0.012508:0.007466:0.005022:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005034:0.015990:0.003848:0.006523:0.011738:0.005022:0.011680:0.015644:0.015644:0.005022:0.011738:0.013143:0.010660:0.012508:0.005330
been  described.  Specific  inherited  syn-:@0.524249:0.160679:0.915148:0.160679:0.915148:0.144923:0.524249:0.144923:0.013123:0.012508:0.012508:0.011738:0.005330:0.007347:0.013181:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.012508:0.013181:0.005330:0.005330:0.007351:0.009583:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330:0.007351:0.003848:0.011738:0.011738:0.012508:0.005792:0.003848:0.006523:0.012508:0.013181:0.005330:0.007345:0.007466:0.010314:0.011738:0.006388
dromes associated  with renal cell carci-:@0.524249:0.177083:0.915162:0.177083:0.915162:0.161327:0.524249:0.161327:0.013181:0.005713:0.012604:0.018049:0.012508:0.007466:0.009487:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330:0.004147:0.015990:0.003848:0.006523:0.011738:0.009487:0.005711:0.012508:0.011738:0.013143:0.003848:0.009487:0.012450:0.012508:0.003848:0.003848:0.009487:0.012450:0.013143:0.005657:0.012450:0.003848:0.006388
noma include von Hippel-Lindau disease, :@0.524249:0.193487:0.920494:0.193487:0.920494:0.177731:0.524249:0.177731:0.011738:0.012604:0.018049:0.013143:0.006783:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.006793:0.010660:0.012604:0.011738:0.006793:0.013143:0.003848:0.013123:0.013123:0.012508:0.003848:0.006388:0.008890:0.003848:0.011738:0.013196:0.013143:0.011699:0.006793:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
tuberous sclerosis complex, hereditary :@0.524249:0.209891:0.920496:0.209891:0.920496:0.194135:0.524249:0.194135:0.006523:0.011699:0.013123:0.012508:0.005709:0.012604:0.011699:0.007466:0.017934:0.007466:0.012450:0.003848:0.012508:0.005717:0.012604:0.007466:0.003848:0.007466:0.017934:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.009236:0.005330:0.017934:0.011738:0.012508:0.005707:0.012508:0.013181:0.003848:0.006523:0.013143:0.005792:0.010314:0.005330
papillary renal carcinoma, hereditary par-:@0.524249:0.226295:0.915154:0.226295:0.915154:0.210539:0.524249:0.210539:0.013123:0.013143:0.013123:0.003848:0.003848:0.003848:0.013143:0.005792:0.010314:0.005428:0.005713:0.012508:0.011738:0.013143:0.003848:0.005407:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.005407:0.011738:0.012508:0.005711:0.012508:0.013181:0.003848:0.006523:0.013143:0.005792:0.010314:0.005407:0.013123:0.013143:0.005792:0.006388
aganglioma and pheochromocytoma. :@0.524249:0.242699:0.920496:0.242699:0.920496:0.226944:0.524249:0.226944:0.013143:0.012950:0.013143:0.011738:0.012950:0.003848:0.003848:0.012604:0.018049:0.013143:0.017953:0.013143:0.011738:0.013181:0.017953:0.013123:0.011738:0.012508:0.012604:0.012450:0.011738:0.005703:0.012604:0.018049:0.012604:0.012450:0.010314:0.006523:0.012604:0.018049:0.013143:0.005330:0.005330
Factors that favour a hereditary contribu-:@0.524249:0.259104:0.915158:0.259104:0.915158:0.243348:0.524249:0.243348:0.009333:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.006629:0.006523:0.011738:0.013143:0.006523:0.006639:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.006639:0.013143:0.006639:0.011738:0.012508:0.005709:0.012508:0.013181:0.003848:0.006523:0.013143:0.005792:0.010314:0.006639:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011676:0.006388
tion  in  patients without  a  clear  genetic :@0.524249:0.275508:0.920504:0.275508:0.920504:0.259752:0.524249:0.259752:0.006523:0.003848:0.012604:0.011738:0.005330:0.005234:0.003848:0.011738:0.005330:0.005242:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.010583:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330:0.005230:0.013143:0.005330:0.005244:0.012450:0.003848:0.012508:0.013143:0.005792:0.005330:0.005236:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005330
disease include first-degree relatives with :@0.524249:0.291912:0.920486:0.291912:0.920486:0.276156:0.524249:0.276156:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.008082:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.008070:0.004686:0.004686:0.005792:0.007466:0.006523:0.006388:0.013181:0.012508:0.012950:0.005703:0.012508:0.012508:0.008066:0.005713:0.012508:0.003848:0.013143:0.006523:0.003848:0.010660:0.012508:0.007466:0.008082:0.015990:0.003848:0.006523:0.011738:0.005330
a tumour, onset before the age of 40, and :@0.524249:0.308316:0.920477:0.308316:0.920477:0.292560:0.524249:0.292560:0.013143:0.005253:0.006523:0.011699:0.018049:0.012604:0.011699:0.003768:0.005330:0.005253:0.012604:0.011738:0.007466:0.012508:0.006523:0.005253:0.013123:0.012508:0.006042:0.012604:0.005707:0.012508:0.005253:0.006523:0.011738:0.012508:0.005253:0.013143:0.012950:0.012508:0.005253:0.012604:0.006042:0.005253:0.010660:0.010660:0.005330:0.005253:0.013143:0.011738:0.013181:0.005330
bilateral or multifocal disease.:@0.524249:0.324720:0.801917:0.324720:0.801917:0.308964:0.524249:0.308964:0.013123:0.003848:0.003848:0.013143:0.006523:0.012508:0.005792:0.013143:0.003848:0.005330:0.012604:0.005792:0.005330:0.018049:0.011699:0.003848:0.006523:0.003848:0.006042:0.012604:0.012450:0.013143:0.003848:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
PATHOLOGY :@0.524242:0.357945:0.658083:0.357945:0.658083:0.340130:0.524242:0.340130:0.011973:0.015822:0.008980:0.014539:0.017960:0.009407:0.017960:0.017960:0.013256:0.005987
All solid renal masses require resection or :@0.524242:0.375498:0.920474:0.375498:0.920474:0.359742:0.524242:0.359742:0.014239:0.003848:0.003848:0.007678:0.007466:0.012604:0.003848:0.003848:0.013181:0.007685:0.005711:0.012508:0.011738:0.013143:0.003848:0.007685:0.018049:0.013143:0.007466:0.007466:0.012508:0.007466:0.007697:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.007682:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007678:0.012604:0.005792:0.005330
biopsy for  accurate  diagnosis unless the :@0.524242:0.391902:0.920476:0.391902:0.920476:0.376146:0.524242:0.376146:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.009313:0.006042:0.012604:0.005792:0.005330:0.003970:0.013143:0.012450:0.012450:0.011699:0.005792:0.013143:0.006523:0.012508:0.005330:0.003972:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.009313:0.011699:0.011738:0.003848:0.012508:0.007466:0.007466:0.009313:0.006523:0.011738:0.012508:0.005330
presence  of  a metastatic lesion  can be :@0.524242:0.408306:0.920489:0.408306:0.920489:0.392550:0.524242:0.392550:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.005330:0.003991:0.012604:0.006042:0.005330:0.003993:0.013143:0.009333:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.009333:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.005330:0.003993:0.012450:0.013143:0.011738:0.009333:0.013123:0.012508:0.005330
established by biopsy. RCCs are classified :@0.524242:0.424710:0.920470:0.424710:0.920470:0.408954:0.524242:0.408954:0.012508:0.007466:0.006523:0.013143:0.013123:0.003848:0.003848:0.007466:0.011738:0.012508:0.013181:0.006250:0.013123:0.010314:0.006244:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.005330:0.006246:0.011680:0.015644:0.015644:0.007466:0.006240:0.013143:0.005715:0.012508:0.006238:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330
to reflect the morphology, growth pattern, :@0.524242:0.441114:0.920497:0.441114:0.920497:0.425358:0.524242:0.425358:0.006523:0.012604:0.004491:0.005711:0.012508:0.004666:0.004666:0.012508:0.012450:0.006523:0.004493:0.006523:0.011738:0.012508:0.004491:0.018049:0.012604:0.005792:0.013123:0.011738:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.004482:0.012950:0.005709:0.012604:0.015990:0.006523:0.011738:0.004493:0.013123:0.013143:0.006523:0.006523:0.012508:0.006188:0.011738:0.005330:0.005330
cell of origin, and the histochemical and :@0.524242:0.457519:0.920491:0.457519:0.920491:0.441763:0.524242:0.441763:0.012450:0.012508:0.003848:0.003848:0.007735:0.012604:0.006042:0.007735:0.012604:0.005792:0.003848:0.012950:0.003848:0.011738:0.005330:0.007726:0.013143:0.011738:0.013181:0.007735:0.006523:0.011738:0.012508:0.007735:0.011738:0.003848:0.007466:0.006523:0.012604:0.012450:0.011738:0.012508:0.018049:0.003848:0.012450:0.013143:0.003848:0.007735:0.013143:0.011738:0.013181:0.005330
molecular basis  of the different types of :@0.524242:0.473923:0.920497:0.473923:0.920497:0.458167:0.524242:0.458167:0.018049:0.012604:0.003848:0.012508:0.012450:0.011699:0.003848:0.013143:0.005792:0.009294:0.013123:0.013143:0.007466:0.003848:0.007466:0.005330:0.003981:0.012604:0.006042:0.009294:0.006523:0.011738:0.012508:0.009294:0.013181:0.003848:0.006104:0.006042:0.012508:0.005709:0.012508:0.011738:0.006523:0.009294:0.006523:0.010314:0.013123:0.012508:0.007466:0.009294:0.012604:0.006042:0.005330
adenocarcinomas.:@0.524242:0.490327:0.703287:0.490327:0.703287:0.474571:0.524242:0.474571:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005651:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330
The subtypes of RCC include::@0.524242:0.523135:0.796445:0.523135:0.796445:0.507379:0.524242:0.507379:0.008197:0.011738:0.012508:0.005330:0.007466:0.011699:0.013123:0.006523:0.010314:0.013123:0.012508:0.007466:0.005330:0.012604:0.006042:0.005330:0.011680:0.015644:0.015644:0.005330:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
n   :@0.524242:0.536439:0.547050:0.536439:0.547050:0.527999:0.524242:0.527999:0.009762:0.003566:0.005914:0.003566
Clear-cell (75-85%):@0.543484:0.539558:0.716935:0.539558:0.716935:0.523803:0.543484:0.523803:0.015644:0.003848:0.012508:0.013143:0.005792:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.007100:0.010660:0.010660:0.006388:0.010660:0.010660:0.014913:0.007100
n   :@0.524242:0.552845:0.547050:0.552845:0.547050:0.544405:0.524242:0.544405:0.009762:0.003566:0.005914:0.003566
Papillary (chromophilic 10-15%):@0.543484:0.555964:0.832761:0.555964:0.832761:0.540208:0.543484:0.540208:0.011392:0.013143:0.013123:0.003848:0.003848:0.003848:0.013143:0.005792:0.010314:0.005330:0.007100:0.012450:0.011738:0.005721:0.012604:0.018049:0.012604:0.013123:0.011738:0.003848:0.003848:0.003848:0.012450:0.005330:0.010660:0.010660:0.006388:0.010660:0.010660:0.014913:0.007100
n   :@0.524242:0.569251:0.547050:0.569251:0.547050:0.560811:0.524242:0.560811:0.009762:0.003566:0.005914:0.003566
Chromophobe (5-10%):@0.543484:0.572370:0.755741:0.572370:0.755741:0.556615:0.543484:0.556615:0.015644:0.011738:0.005709:0.012604:0.018049:0.012604:0.013123:0.011738:0.012604:0.013123:0.012508:0.005330:0.007100:0.010660:0.006388:0.010660:0.010660:0.014913:0.007100
n   :@0.524242:0.585657:0.547050:0.585657:0.547050:0.577217:0.524242:0.577217:0.009762:0.003566:0.005914:0.003566
Oncocytic:@0.543484:0.588777:0.642583:0.588777:0.642583:0.573021:0.543484:0.573021:0.016722:0.011738:0.012450:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450
n   :@0.524242:0.602063:0.547050:0.602063:0.547050:0.593623:0.524242:0.593623:0.009762:0.003566:0.005914:0.003566
Collecting duct (Bellini’s duct):@0.543484:0.605183:0.822249:0.605183:0.822249:0.589427:0.543484:0.589427:0.015644:0.012604:0.003848:0.003848:0.012508:0.012450:0.006523:0.003848:0.011738:0.012950:0.005330:0.013181:0.011699:0.012450:0.006523:0.005330:0.007100:0.011045:0.012508:0.003848:0.003848:0.003848:0.011738:0.003848:0.006754:0.007466:0.005330:0.013181:0.011699:0.012450:0.006523:0.007100
Clear-cell carcinomas  typically have  a :@0.524242:0.637991:0.920483:0.637991:0.920483:0.622235:0.524242:0.622235:0.015644:0.003848:0.012508:0.013143:0.005792:0.006388:0.012450:0.012508:0.003848:0.003848:0.012950:0.012450:0.013143:0.005659:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330:0.007610:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.012950:0.011738:0.013143:0.010660:0.012508:0.005330:0.007610:0.013143:0.005330
deletion  of  chromosome  3p and arise :@0.524242:0.654395:0.920479:0.654395:0.920479:0.638639:0.524242:0.638639:0.013181:0.012508:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.005330:0.008091:0.012604:0.006042:0.005330:0.008091:0.012450:0.011738:0.005709:0.012604:0.018049:0.012604:0.007466:0.012604:0.018049:0.012508:0.005330:0.008086:0.010660:0.013123:0.013431:0.013143:0.011738:0.013181:0.013431:0.013143:0.005792:0.003848:0.007466:0.012508:0.005330
from the proximal tubule. A poor prognosis :@0.524242:0.670799:0.920506:0.670799:0.920506:0.655043:0.524242:0.655043:0.006042:0.005711:0.012604:0.018049:0.004599:0.006523:0.011738:0.012508:0.004599:0.013123:0.005715:0.012604:0.009236:0.003848:0.018049:0.013143:0.003848:0.004599:0.006523:0.011699:0.013123:0.011699:0.003848:0.012508:0.005330:0.004599:0.014239:0.004599:0.013123:0.012604:0.012604:0.005792:0.004589:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
is associated with a higher nuclear grade :@0.524242:0.687203:0.920474:0.687203:0.920474:0.671447:0.524242:0.671447:0.003848:0.007466:0.006458:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.006446:0.015990:0.003848:0.006523:0.011738:0.006446:0.013143:0.006446:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792:0.006446:0.011738:0.011699:0.012450:0.003848:0.012508:0.013143:0.005792:0.006446:0.012950:0.005792:0.013143:0.013181:0.012508:0.005330
or the presence of a sarcomatoid pattern.:@0.524242:0.703608:0.915170:0.703608:0.915170:0.687852:0.524242:0.687852:0.012604:0.005792:0.004695:0.006523:0.011738:0.012508:0.004697:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.004703:0.012604:0.006042:0.004699:0.013143:0.004714:0.007466:0.013143:0.005663:0.012450:0.012604:0.018049:0.013143:0.006523:0.012604:0.003848:0.013181:0.004703:0.013123:0.013143:0.006523:0.006523:0.012508:0.006188:0.011738:0.005330
TREATMENT:@0.524242:0.736754:0.636703:0.736754:0.636703:0.718939:0.524242:0.718939:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980
Localised (resectable) RCC:@0.524242:0.754629:0.807319:0.754629:0.807319:0.736607:0.524242:0.736607:0.009407:0.013683:0.013683:0.014111:0.005131:0.005131:0.009407:0.013683:0.014111:0.005987:0.008125:0.006842:0.013683:0.009407:0.013683:0.013683:0.006414:0.014111:0.014111:0.005131:0.013683:0.008125:0.005987:0.012401:0.016677:0.016677
Surgery is potentially curative in the ma-:@0.524242:0.772183:0.915165:0.772183:0.915165:0.756427:0.524242:0.756427:0.009390:0.011507:0.005613:0.012758:0.012315:0.005600:0.010122:0.009852:0.003656:0.007274:0.009852:0.012931:0.012411:0.006331:0.012315:0.011545:0.006331:0.003656:0.012950:0.003656:0.003656:0.010122:0.009852:0.012257:0.011507:0.005600:0.012950:0.006331:0.003656:0.010468:0.012315:0.009852:0.003656:0.011545:0.009852:0.006331:0.011545:0.012315:0.009852:0.017857:0.012950:0.006388
jority of patients with localised RCC and :@0.524242:0.788587:0.920445:0.788587:0.920445:0.772831:0.524242:0.772831:0.003714:0.012411:0.005600:0.003656:0.006331:0.010122:0.009814:0.012411:0.005850:0.009814:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.009814:0.015798:0.003656:0.006331:0.011545:0.009814:0.003656:0.012411:0.012257:0.012950:0.003656:0.003656:0.007274:0.012315:0.012989:0.009814:0.011488:0.015452:0.015452:0.009814:0.012950:0.011545:0.013183:0.005330
is  therefore the preferred treatment  for :@0.524242:0.804991:0.920541:0.804991:0.920541:0.789235:0.524242:0.789235:0.003656:0.007274:0.005330:0.007630:0.006331:0.011545:0.012315:0.005521:0.012315:0.005850:0.012411:0.005519:0.012315:0.012969:0.006331:0.011545:0.012315:0.012969:0.012931:0.005521:0.012315:0.005850:0.012315:0.005600:0.005521:0.012315:0.012989:0.012969:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005330:0.007630:0.005850:0.012411:0.005788:0.005330
patients  with  stages  I,  II  and  III  disease. :@0.524242:0.821396:0.920458:0.821396:0.920458:0.805640:0.524242:0.805640:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005330:0.006050:0.015798:0.003656:0.006331:0.011545:0.005330:0.006050:0.007274:0.006331:0.012950:0.012758:0.012315:0.007274:0.005330:0.006050:0.004156:0.005138:0.005330:0.006050:0.004156:0.004156:0.005330:0.006050:0.012950:0.011545:0.012989:0.005330:0.006052:0.004156:0.004156:0.004156:0.005330:0.006050:0.012989:0.003656:0.007274:0.012315:0.012950:0.007274:0.012315:0.005328:0.005330
Treatment can involve either a radical ne-:@0.524242:0.837800:0.915157:0.837800:0.915157:0.822044:0.524242:0.822044:0.007428:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.006338:0.012257:0.012950:0.011545:0.006338:0.003656:0.011545:0.010468:0.012411:0.003656:0.010468:0.012315:0.006338:0.012315:0.003656:0.006331:0.011545:0.012315:0.005600:0.006338:0.012950:0.006338:0.005600:0.012950:0.012989:0.003656:0.012257:0.012950:0.003656:0.006338:0.011545:0.012315:0.006388
phrectomy or a variety of renal-sparing ap-:@0.524242:0.854204:0.915184:0.854204:0.915184:0.838448:0.524242:0.838448:0.012931:0.011545:0.005519:0.012315:0.012257:0.006331:0.012411:0.017857:0.010122:0.004637:0.012411:0.005600:0.004637:0.012950:0.004637:0.010468:0.012950:0.005600:0.003656:0.012315:0.006331:0.010122:0.004637:0.012411:0.005850:0.004637:0.005521:0.012315:0.011545:0.012950:0.003656:0.006196:0.007274:0.012931:0.012950:0.005600:0.003656:0.011545:0.012758:0.004637:0.012950:0.012931:0.006388
proaches (partial nephrectomy or ablative :@0.524242:0.870608:0.920456:0.870608:0.920456:0.854852:0.524242:0.854852:0.012931:0.005521:0.012411:0.012950:0.012257:0.011545:0.012315:0.007274:0.005022:0.006908:0.012931:0.012950:0.005600:0.006331:0.003656:0.012950:0.003656:0.005022:0.011545:0.012315:0.012931:0.011545:0.005521:0.012315:0.012257:0.006331:0.012411:0.017857:0.010122:0.005022:0.012411:0.005600:0.005022:0.012950:0.012931:0.003656:0.012950:0.006331:0.003656:0.010468:0.012506:0.005330
techniques) in carefully selected patients, :@0.524242:0.887012:0.920474:0.887012:0.920474:0.871256:0.524242:0.871256:0.006331:0.012315:0.012257:0.011545:0.011545:0.003656:0.012931:0.011507:0.012315:0.007274:0.006908:0.007793:0.003656:0.011545:0.007793:0.012257:0.012950:0.005519:0.012315:0.005850:0.011507:0.003656:0.003656:0.010122:0.007793:0.007274:0.012315:0.003656:0.012315:0.012257:0.006331:0.012315:0.012989:0.007793:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005326:0.005330
depending upon the extent of disease.:@0.524242:0.903416:0.881804:0.903416:0.881804:0.887660:0.524242:0.887660:0.012989:0.012315:0.012931:0.012315:0.011545:0.012989:0.003656:0.011545:0.012758:0.005138:0.011507:0.012931:0.012411:0.011545:0.005138:0.006331:0.011545:0.012315:0.005138:0.012315:0.009044:0.006331:0.012315:0.011545:0.006331:0.005138:0.012411:0.005850:0.005138:0.012989:0.003656:0.007274:0.012315:0.012950:0.007274:0.012315:0.005330
Patients who are not candidates for sur-:@0.542426:0.919821:0.915161:0.919821:0.915161:0.904065:0.542426:0.904065:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005677:0.015990:0.011738:0.012604:0.005677:0.013143:0.005713:0.012508:0.005677:0.011738:0.012604:0.006523:0.005677:0.012450:0.013143:0.011738:0.013181:0.003848:0.013181:0.013143:0.006523:0.012508:0.007466:0.005688:0.006042:0.012604:0.005792:0.005677:0.007466:0.011699:0.005792:0.006388
gical resection,  such  as elderly  patients :@0.524242:0.936225:0.920497:0.936225:0.920497:0.920469:0.524242:0.920469:0.012950:0.003848:0.012450:0.013143:0.003848:0.010641:0.005711:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.005296:0.007466:0.011699:0.012450:0.011738:0.005330:0.005297:0.013143:0.007466:0.010641:0.012508:0.003848:0.013181:0.012508:0.005792:0.003848:0.010314:0.005330:0.005301:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
Kidney and Bladder Cancers:@0.084848:0.111850:0.680935:0.111850:0.680935:0.076219:0.084848:0.076219:0.026512:0.010263:0.028222:0.025657:0.027367:0.024801:0.011973:0.028222:0.025657:0.028222:0.011973:0.024801:0.010263:0.028222:0.028222:0.028222:0.027367:0.013683:0.011973:0.033354:0.028222:0.025657:0.027367:0.027367:0.013683:0.018815